Dnb Asset Management As Has Raised Mccormick & Co Inc/Md (MKC) Stake By $87.76 Million; Jpmorgan Chase & Company Has Raised Synergy Pharmaceuticals Del (SGYP) Position By $3.01 Million

December 1, 2017 - By Hazel Jackson

Dnb Asset Management As increased Mccormick & Co Inc/Md (MKC) stake by 5.02% reported in 2017Q2 SEC filing. Dnb Asset Management As acquired 900 shares as Mccormick & Co Inc/Md (MKC)’s stock rose 3.48%. The Dnb Asset Management As holds 18,819 shares with $1.84B value, up from 17,919 last quarter. Mccormick & Co Inc/Md now has $13.42 billion valuation. The stock increased 0.26% or $0.27 during the last trading session, reaching $102.45. About 391,492 shares traded. McCormick & Company, Incorporated (NYSE:MKC) has risen 5.12% since December 1, 2016 and is uptrending. It has underperformed by 11.58% the S&P500.

Jpmorgan Chase & Company increased Synergy Pharmaceuticals Del (SGYP) stake by 60.89% reported in 2017Q2 SEC filing. Jpmorgan Chase & Company acquired 752,475 shares as Synergy Pharmaceuticals Del (SGYP)’s stock declined 35.42%. The Jpmorgan Chase & Company holds 1.99 million shares with $8.85M value, up from 1.24M last quarter. Synergy Pharmaceuticals Del now has $500.10M valuation. The stock decreased 2.52% or $0.05 during the last trading session, reaching $2.03. About 4.16 million shares traded. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has risen 24.44% since December 1, 2016 and is uptrending. It has outperformed by 7.74% the S&P500.

Jpmorgan Chase & Company decreased Landstar Sys Inc (NASDAQ:LSTR) stake by 40,895 shares to 1.44M valued at $123.33M in 2017Q2. It also reduced Ameren Corp (NYSE:AEE) stake by 3.33M shares and now owns 470,071 shares. Axalta Coating Sys Ltd was reduced too.

Among 8 analysts covering Synergy Pharmaceuticals (NASDAQ:SGYP), 7 have Buy rating, 1 Sell and 0 Hold. Therefore 88% are positive. Synergy Pharmaceuticals had 32 analyst reports since August 25, 2015 according to SRatingsIntel. As per Thursday, August 10, the company rating was maintained by Oppenheimer. The rating was maintained by Cantor Fitzgerald on Wednesday, September 27 with “Buy”. On Thursday, April 6 the stock rating was downgraded by Citigroup to “Sell”. The firm earned “Sell” rating on Wednesday, September 13 by Citigroup. The rating was maintained by Canaccord Genuity on Friday, November 10 with “Buy”. Oppenheimer initiated Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) on Thursday, January 5 with “Outperform” rating. The stock of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) has “Buy” rating given on Thursday, June 1 by Cantor Fitzgerald. The rating was maintained by Rodman & Renshaw with “Buy” on Monday, March 21. The firm has “Buy” rating given on Monday, June 12 by H.C. Wainwright. Cantor Fitzgerald maintained the shares of SGYP in report on Wednesday, August 9 with “Buy” rating.

Investors sentiment decreased to 1.49 in Q2 2017. Its down 0.45, from 1.94 in 2017Q1. It is negative, as 31 investors sold SGYP shares while 22 reduced holdings. 20 funds opened positions while 59 raised stakes. 158.68 million shares or 6.77% more from 148.62 million shares in 2017Q1 were reported. 11,000 are held by Williams Jones & Associate Ltd Com. Phoenix Invest Adviser Lc has invested 0.05% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Edge Wealth Mgmt Limited Liability has invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Great West Life Assurance Can, a Manitoba – Canada-based fund reported 22,700 shares. Bruce Company owns 100,000 shares. Victory Cap Mgmt owns 5,015 shares for 0% of their portfolio. Sg Americas Securities Limited Liability Com holds 22,002 shares. New York-based Citigroup Inc has invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). The Germany-based Deutsche Retail Bank Ag has invested 0% in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Credit Agricole S A reported 0% stake. Hsbc Public Ltd has invested 0% of its portfolio in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). Dekabank Deutsche Girozentrale has 0% invested in Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) for 101,000 shares. 133,159 were accumulated by Cornerstone Mgmt Hldg Ltd Co. Captrust holds 0.01% or 27,509 shares in its portfolio. Susquehanna Int Grp Llp accumulated 2.40M shares.

Dnb Asset Management As decreased Red Hat Inc (NYSE:RHT) stake by 39,010 shares to 19,446 valued at $1.86 billion in 2017Q2. It also reduced Clorox Co/The (NYSE:CLX) stake by 1,200 shares and now owns 15,540 shares. Nucor Corp (NYSE:NUE) was reduced too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>